Literature DB >> 29958635

Tafro syndrome: Critical review for clinicians and pathologists.

Semra Paydas1.   

Abstract

TAFRO is an acrostic and includes thrombocytopenia (T), anasarca (A), fever (F), reticulin fibrosis (R) and organomegaly (O) (Takai et al., 2013). TAFRO syndrome has been described firstly by Takai in Japanese patients. However TAFRO cases have been reported from US, Europe and other countries (Takai et al., 2010; Iwaki et al., 2016; Abdo et al., 2014). Three major and at least one minor criteria and exclusion of infectious, rheumatologic and neoplastic diseases are required for the diagnosis of TAFRO. In fact TAFRO must be thought in clinically undiagnosed and unsolved problemmatic cases.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anasarca; Castleman disease; Fever; Organomegaly; Reticulin fibrosis; TAFRO

Mesh:

Year:  2018        PMID: 29958635     DOI: 10.1016/j.critrevonc.2018.05.015

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


  3 in total

1.  Unexplained cause of thrombocytopenia, fever, anasarca and hypothyroidism: TAFRO syndrome with thrombotic microangiopathy renal histology.

Authors:  Sylvain Raoul Simeni Njonnou; Justine Deuson; Claire Royer-Chardon; Frédéric Alain Vandergheynst; Virginie De Wilde
Journal:  BMJ Case Rep       Date:  2020-06-30

2.  Castleman disease: Case series of two surgical patients from different ends of the disease spectrum with literature review.

Authors:  Radhika Raj C G; Suresh B
Journal:  Int J Surg Case Rep       Date:  2018-10-29

3.  A Rare Variant of Idiopathic Multicentric Castleman Disease: TAFRO Syndrome

Authors:  Ece Ük; Alper Akın; Übeyde Ayşe Gülseren; Simge Erdem; Alpay Medetalibeyoğlu
Journal:  Turk J Haematol       Date:  2022-06-14       Impact factor: 2.029

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.